Program Information
Sensitivity of Patient Specific IMRT QA to Errors in the Dosimetric Leaf Gap
D Bollinger*, B Sun , Washington Univ. in St. Louis, St. Louis, MO
Presentations
SU-I-GPD-T-274 (Sunday, July 30, 2017) 3:00 PM - 6:00 PM Room: Exhibit Hall
Purpose: Precise knowledge of the dosimetric leaf gap (DLG) is critical for accurate delivery of dynamic IMRT plans. The purpose of this work is to evaluate the sensitivity of various patient-specific IMRT QA methods to DLG errors.
Methods: Ion chamber (IC) measurements were used to derive the DLG for three different photon energies on a TrueBeam and compared with the DLG values from the treatment planning system (TPS). Three different IMRT approaches were used to evaluate the dosimetric effect of the DLG: Matrixx (2d ion chamber array) measurements, point dose measurements with an IC, and portal dosimetry. To encompass a variety of levels of intensity modulation, seven patient plans of different treatment sites were chosen.
Results: The DLG values were derived at central axis to be 0.9, 1.1, and 0.7 mm for 6MV, 10 MV and 6FFF, respectively. These values were 1 mm less than the configured values in the TPS. The average gamma passing rate using Matrixx for the 7 IMRT plans was 92.89% with 1-2% scalling. The average point dose measured with the ion chamber was 4.7% lower than the calculated value from the TPS. The average passing rate using portal dosimetry was 73.9% for the 2%/ 2mm criteria and 92.6% for the 3%/ 3mm criteria. After the DLG was adjusted to match the values in the TPS, the average passing rate of Matrixx measurements increased to 97.6%, and the passing rate in portal dosimetry increased to 97.6% and 99.3% for 2% /2 mm and 3%/3mm respectively.
Conclusion: It is estimated that a systematic MLC leaf gap error of 1 mm will result in a 4.7% dose difference between the TPS predicted and measured dose. Both point dose measurements with an ion chamber and portal dosimetry show higher sensitivity to the errors in the DLG.
Contact Email: